← Back to RCKT

Rocket Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
$0$0$0$0$0$0$0$0
$123−$48−$50−$69−$61−$67−$70−$62
$1.08−$0.42−$0.45−$0.62−$0.56−$0.71−$0.74−$0.66
115112112111110949494

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.